Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registry-based control group

BACKGROUND AND OBJECTIVES: Rheumatoid arthritis (RA) causes considerable disability and often results in loss of work capacity and productivity. This study evaluated the impact of adalimumab, a tumour necrosis factor antagonist with demonstrated efficacy in RA, on long-term employment. METHODS: Data...

Descripción completa

Detalles Bibliográficos
Autores principales: Halpern, M T, Cifaldi, M A, Kvien, T K
Formato: Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2008
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674552/
https://www.ncbi.nlm.nih.gov/pubmed/18829616
http://dx.doi.org/10.1136/ard.2008.092734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674552/
https://www.ncbi.nlm.nih.gov/pubmed/18829616
http://dx.doi.org/10.1136/ard.2008.092734

Ejemplares similares